193 related articles for article (PubMed ID: 18786931)
1. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration.
Kim TY; Healy KD; Der CJ; Sciaky N; Bang YJ; Juliano RL
J Biol Chem; 2008 Nov; 283(47):32762-70. PubMed ID: 18786931
[TBL] [Abstract][Full Text] [Related]
2. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
[TBL] [Abstract][Full Text] [Related]
3. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.
Kim TY; Vigil D; Der CJ; Juliano RL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):77-83. PubMed ID: 19221866
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.
Liao YC; Shih YP; Lo SH
Cancer Res; 2008 Oct; 68(19):7718-22. PubMed ID: 18829524
[TBL] [Abstract][Full Text] [Related]
5. Identifying Cancer-Relevant Mutations in the DLC START Domain Using Evolutionary and Structure-Function Analyses.
Holub AS; Bouley RA; Petreaca RC; Husbands AY
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142932
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology.
Kawai K; Iwamae Y; Yamaga M; Kiyota M; Ishii H; Hirata H; Homma Y; Yagisawa H
Genes Cells; 2009 Feb; 14(2):227-41. PubMed ID: 19170769
[TBL] [Abstract][Full Text] [Related]
7. DLC-1:a Rho GTPase-activating protein and tumour suppressor.
Durkin ME; Yuan BZ; Zhou X; Zimonjic DB; Lowy DR; Thorgeirsson SS; Popescu NC
J Cell Mol Med; 2007; 11(5):1185-207. PubMed ID: 17979893
[TBL] [Abstract][Full Text] [Related]
8. Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger.
Jaiswal M; Dvorsky R; Amin E; Risse SL; Fansa EK; Zhang SC; Taha MS; Gauhar AR; Nakhaei-Rad S; Kordes C; Koessmeier KT; Cirstea IC; Olayioye MA; Häussinger D; Ahmadian MR
J Biol Chem; 2014 Mar; 289(10):6839-6849. PubMed ID: 24443565
[TBL] [Abstract][Full Text] [Related]
9. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
[TBL] [Abstract][Full Text] [Related]
10. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
Sun J; Barbieri JT
J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
[TBL] [Abstract][Full Text] [Related]
11. Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion.
Hall EH; Daugherty AE; Choi CK; Horwitz AF; Brautigan DL
J Biol Chem; 2009 Dec; 284(50):34713-22. PubMed ID: 19826001
[TBL] [Abstract][Full Text] [Related]
12. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration.
Zhong D; Zhang J; Yang S; Soh UJ; Buschdorf JP; Zhou YT; Yang D; Low BC
J Cell Sci; 2009 Feb; 122(Pt 3):414-24. PubMed ID: 19158340
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins.
Nagaraja GM; Kandpal RP
Biochem Biophys Res Commun; 2004 Jan; 313(3):654-65. PubMed ID: 14697242
[TBL] [Abstract][Full Text] [Related]
14. SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP.
Chau JE; Vish KJ; Boggon TJ; Stiegler AL
Nat Commun; 2022 Aug; 13(1):4788. PubMed ID: 35970859
[TBL] [Abstract][Full Text] [Related]
15. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
Liao YC; Lo SH
Int J Biochem Cell Biol; 2008; 40(5):843-7. PubMed ID: 17521951
[TBL] [Abstract][Full Text] [Related]
16. p200 RhoGAP promotes cell proliferation by mediating cross-talk between Ras and Rho signaling pathways.
Shang X; Moon SY; Zheng Y
J Biol Chem; 2007 Mar; 282(12):8801-11. PubMed ID: 17272280
[TBL] [Abstract][Full Text] [Related]
17. A novel Rho GTPase-activating-protein interacts with Gem, a member of the Ras superfamily of GTPases.
Aresta S; de Tand-Heim MF; Béranger F; de Gunzburg J
Biochem J; 2002 Oct; 367(Pt 1):57-65. PubMed ID: 12093360
[TBL] [Abstract][Full Text] [Related]
18. Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity.
Barker TH; Grenett HE; MacEwen MW; Tilden SG; Fuller GM; Settleman J; Woods A; Murphy-Ullrich J; Hagood JS
Exp Cell Res; 2004 May; 295(2):488-96. PubMed ID: 15093746
[TBL] [Abstract][Full Text] [Related]
19. Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1.
Shang X; Zhou YT; Low BC
J Biol Chem; 2003 Nov; 278(46):45903-14. PubMed ID: 12944407
[TBL] [Abstract][Full Text] [Related]
20. The GRAF family member oligophrenin1 is a RhoGAP with BAR domain and regulates Rho GTPases in platelets.
Elvers M; Beck S; Fotinos A; Ziegler M; Gawaz M
Cardiovasc Res; 2012 Jun; 94(3):526-36. PubMed ID: 22298643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
